Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease

NCT01239069 is registered in ClinicalTrials.gov with Santen Inc. as lead sponsor.

NCT NCT01239069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01239069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Lead sponsor
Santen Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2010
Completion date
October 31, 2011
Enrollment
140 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye